The Mirena IUD (Intra-Uterine Device) was given FDA approval as a long acting form of birth control and for treatment of heavy menstrual bleeding. It is a T-shaped device that is inserted into a woman’s uterus in order to prevent fertilization. In addition, the device also releases a synthetic form of progesterone known as levonorgestrel, to stop a woman from producing and releasing an egg.
Manufactured by Bayer, Mirena has been promoted as a safe and long-term reversible form of birth control. However, Bayer may have sold the device without properly warning women about the potential risks associated with Mirena. Major complications are linked to the IUD’s potential to move inside the body resulting in numerous side effects, including the following: perforation of the uterine wall; migration of the IUD to outside the uterus; infection; infertility; pelvic inflammatory disease; and expulsion of the IUD.
On January 14, 2010, an FDA warning letter was sent to Bayer concerning its live consumer directed program. The letter states that Bayer “overstates the efficacy of Mirena, presents unsubstantiated claims, minimizes the risks of using Mirena, and includes false or misleading presentations regarding Mirena.”
As lawsuits from women who were injured while using the Mirena IUD grow in New Jersey state court, Bayer Pharmaceuticals has recently sought to consolidate the lawsuit in a New Jersey court.
If you or a loved one has experienced complications as a result of Mirena please contact the attorneys at Pogust Braslow & Millrood immediately.